Botulinum Toxin for the Treatment of Tremor and Tics

Seminars in Neurology

Volumn 36, Issue 1, 2016, Pages 54-63

  Lotia, Mitesh ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

botulinum toxin; essential tremor; tics; tremor

Indexed keywords

BOTULINUM TOXIN; ACETYLCHOLINE RELEASE INHIBITOR;

ANTI MYELIN ASSOCIATED GLYCOPROTEIN NEUROPATHY RELATED ARM TREMOR; ARTICLE; CONTROLLED CLINICAL TRIAL (TOPIC); CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAPHY; ESSENTIAL TREMOR; ESSENTIAL VOICE TREMOR; EVIDENCE BASED PRACTICE; EXTENSOR MUSCLE; HAND GRIP; HAND TREMOR; HEAD TREMOR; HOLMES TREMOR; HUMAN; JAW TREMOR; MULTIPLE SCLEROSIS; MUSCLE CONTRACTION; MYOCLONUS; OSCILLATION; PALATAL MYOCLONUS; PRIMARY WRITING TREMOR; PRIORITY JOURNAL; PROXIMAL ARM TREMOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); REST TREMOR; SYSTEMATIC REVIEW (TOPIC); TIC; TREMOR; VOICE; VOICE DISORDER; ANIMAL; PATHOPHYSIOLOGY; TICS; TREATMENT OUTCOME;

ACETYLCHOLINE RELEASE INHIBITORS; ANIMALS; BOTULINUM TOXINS; HUMANS; TICS; TREATMENT OUTCOME; TREMOR;

EID: 84958191331     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0035-1571217     Document Type: Article

References (61)

1. Ramirez-Castaneda J., Jankovic J. Long-term efficacy, safety, and side effect profile of botulinum toxin in dystonia: A 20-year follow-up. Toxicon: 2014; 90 0 344 348
2. Ramirez-Castaneda J., Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel): 2013; 5 2 249 266
3. Elias W. J., Shah B. B. Tremor. JAMA: 2014; 311 9 948 954
4. Jankovic J., Tolosa E. Parkinson's Disease and Movement Disorders. 6th ed. Philadelphia Lippincott Williams & Wilkins: 2015; 278 297
5. Mostile G., Fekete R., Giuffrida J. P., et al. Amplitude fluctuations in essential tremor. Parkinsonism Relat Disord: 2012; 18 7 859 863
6. Voller B., Lines E., McCrossin G., et al. Alcohol challenge and sensitivity to change of the Essential Tremor Rating Assessment Scale. Mov Disord: 2014; 29 4 555 558
7. Rincon F., Louis E. D. Benefits and risks of pharmacological and surgical treatments for essential tremor: Disease mechanisms and current management. Expert Opin Drug Saf: 2005; 4 5 899 913
8. Jankovic J., Schwartz K. Botulinum toxin treatment of tremors. Neurology: 1991; 41 8 1185 1188
9. Trosch R. M., Pullman S. L. Botulinum toxin A injections for the treatment of hand tremors. Mov Disord: 1994; 9 6 601 609
10. Jankovic J., Schwartz K., Clemence W., Aswad A., Mordaunt J. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord: 1996; 11 3 250 256
11. Brin M. F., Lyons K. E., Doucette J., et al. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology: 2001; 56 11 1523 1528
12. Jankovic J. Disease-oriented approach to botulinum toxin use. Toxicon: 2009; 54 5 614 623
13. Jankovic J. The use of botulinum toxin in tic disorders and essential hand and head tremor. In: Manual of Botulinum Toxin Therapy. 2nd ed. New York Cambridge University Press: 2013; 160 167
14. ClinicalTrials.gov Botulinum toxin A to treat arm tremor. 2015. Available at: https://clinicaltrials.gov/ct2/show/study/NCT02207946 Accessed June 30, 2015
15. Zesiewicz T. A., Shaw J. D., Allison K. G., Staffetti J. S., Okun M. S., Sullivan K. L. Update on treatment of essential tremor. Curr Treat Options Neurol: 2013; 15 4 410 423
16. Hallett M., Albanese A., Dressler D., et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Toxicon: 2013; 67 94 114
17. Louis E. D. Medication non-adherence in essential tremor. Parkinsonism Relat Disord: 2015; 21 2 138 141
18. Pahwa R., Busenbark K., Swanson-Hyland E. F., et al. Botulinum toxin treatment of essential head tremor. Neurology: 1995; 45 4 822 824
19. Fasano A., Bove F., Lang A. E. The treatment of dystonic tremor: A systematic review. J Neurol Neurosurg Psychiatry: 2014; 85 7 759 769
20. Jankovic J. Essential tremor: clinical characteristics. Neurology: 2000; 54 11 04 S21 S25
21. Louis E. D., Ford B., Barnes L. F. Clinical subtypes of essential tremor. Arch Neurol: 2000; 57 8 1194 1198
22. Sulica L., Louis E. D. Clinical characteristics of essential voice tremor: A study of 34 cases. Laryngoscope: 2010; 120 3 516 528
23. Gurey L. E., Sinclair C. F., Blitzer A. A new paradigm for the management of essential vocal tremor with botulinum toxin. Laryngoscope: 2013; 123 10 2497 2501
24. Baizabal-Carvallo J. F., Cardoso F., Jankovic J. Myorhythmia: phenomenology, etiology, and treatment. Mov Disord: 2015; 30 2 171 179
25. Pearce J. M. Palatal myoclonus (syn. palatal tremor). Eur Neurol: 2008; 60 6 312 315
26. Penney S. E., Bruce I. A., Saeed S. R. Botulinum toxin is effective and safe for palatal tremor: A report of five cases and a review of the literature. J Neurol: 2006; 253 7 857 860
27. Thenganatt M. A., Jankovic J. Psychogenic tremor: A video guide to its distinguishing features. Trem Oth Hyperkin Mov (N.Y.): 2014; 4 253
28. Bain P. G., Findley L. J., Britton T. C., et al. Primary writing tremor. Brain: 1995; 118 Pt 6 1461 1472
29. Espay A. J., Hung S. W., Sanger T. D., Moro E., Fox S. H., Lang A. E. A writing device improves writing in primary writing tremor. Neurology: 2005; 64 9 1648 1650
30. Papapetropoulos S., Singer C. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series. Clin Neuropharmacol: 2006; 29 6 364 367
31. Diamond A., Jankovic J. Treatment of advanced Parkinson's disease. Expert Rev Neurother: 2006; 6 8 1181 1197
32. Pullman S. L., Greene P., Fahn S., Pedersen S. F. Approach to the treatment of limb disorders with botulinum toxin A. Experience with 187 patients. Arch Neurol: 1996; 53 7 617 624
33. Henderson J. M., Ghika J. A., Van Melle G., Haller E., Einstein R. Botulinum toxin A in non-dystonic tremors. Eur Neurol: 1996; 36 1 29 35
34. Rahimi F., Bee C., Debicki D., Roberts A. C., Bapat P., Jog M. Effectiveness of BoNT A in Parkinson's disease upper limb tremor management. Can J Neurol Sci: 2013; 40 5 663 669
35. Schneider S. A., Edwards M. J., Cordivari C., Macleod W. N., Bhatia K. P. Botulinum toxin A may be efficacious as treatment for jaw tremor in Parkinson's disease. Mov Disord: 2006; 21 10 1722 1724
36. Tarsy D., Ro S. I. Unusual position-sensitive jaw tremor responsive to botulinum toxin. Mov Disord: 2006; 21 2 277 278
37. Holmes G. On certain tremors in organic cerebral lesions. Brain: 1904; 27 327 375
38. Vélez M., Cosentino C., Torres L. Levodopa-responsive rubral (Holmes') tremor. Mov Disord: 2002; 17 4 741 742
39. Ahn S. Y., Kim D. A., Park Y. O., Shin J. H. Effect of ultrasonography-guided botulinum toxin type a injection in holmes' tremor secondary to pontine hemorrhage: case report. Ann Rehabil Med: 2014; 38 5 694 697
40. Pittock S. J., McClelland R. L., Mayr W. T., Rodriguez M., Matsumoto J. Y. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord: 2004; 19 12 1482 1485
41. Mehanna R., Jankovic J. Movement disorders in multiple sclerosis and other demyelinating diseases. J Neurol Sci: 2013; 328 1-2 1 8
42. Koch M., Mostert J., Heersema D., De Keyser J. Tremor in multiple sclerosis. J Neurol: 2007; 254 2 133 145
43. Van Der Walt A., Sung S., Spelman T., et al. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor. Neurology: 2012; 79 1 92 99
44. Schneider S. A., Deuschl G. Medical and surgical treatment of tremors. Neurol Clin: 2015; 33 1 57 75
45. Bandmann O., Weiss K. H., Kaler S. G. Wilson's disease and other neurological copper disorders. Lancet Neurol: 2015; 14 1 103 113
46. Krauss J. K., Jankovic J. Head injury and posttraumatic movement disorders. Neurosurgery: 2002; 50 5 927 939, discussion 939-940
47. Kitagawa M., Murata J., Kikuchi S., et al. Deep brain stimulation of subthalamic area for severe proximal tremor. Neurology: 2000; 55 1 114 116
48. Kim S. D., Yiannikas C., Mahant N., Vucic S., Fung V. S. Treatment of proximal upper limb tremor with botulinum toxin therapy. Mov Disord: 2014; 29 6 835 838
49. Latino P., Pellicano C., Pontieri F. E., Giovannelli M. Treatment with botulinum toxin for anti-MAG neuropathy-related arm tremor. Neurol Sci: 2015; 36 2 333 334
50. Jankovic J., Kurlan R. Tourette syndrome: Evolving concepts. Mov Disord: 2011; 26 6 1149 1156
51. Scahill L., Chappell P. B., Kim Y. S., et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry: 2001; 158 7 1067 1074
52. Gilbert D. L., Jankovic J. Pharmacological treatment of Tourette syndrome. J Obsessive-Compulsive Relat Disord: 2014; 3 4 407 414
53. Wijemanne S., Wu L. J., Jankovic J. Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord: 2014; 29 1 126 130
54. Jankovic J. Therapeutic developments for tics and myoclonus. Mov Disord: 2015; 30 11 1566 1573
55. Jankovic J. Botulinum toxin in the treatment of dystonic tics. Mov Disord: 1994; 9 3 347 349
56. Patel N., Jankovic J., Hallett M. Sensory aspects of movement disorders. Lancet Neurol: 2014; 13 1 100 112
57. Kwak C. H., Hanna P. A., Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol: 2000; 57 8 1190 1193
58. Marras C., Andrews D., Sime E., Lang A. E. Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial. Neurology: 2001; 56 5 605 610
59. Vincent D. A. Jr. Botulinum toxin in the management of laryngeal tics. J Voice: 2008; 22 2 251 256
60. Porta M., Maggioni G., Ottaviani F., Schindler A. Treatment of phonic tics in patients with Tourette's syndrome using botulinum toxin type A. Neurol Sci: 2004; 24 6 420 423
61. Singer C., Papapetropoulos S., Spielholz F., Schindler N. I. Primary writing tremor: report of a case successfully treated with botulinum toxin A injections and discussion of underlying mechanism. Mov Disord: 2005; 20 10 1387 1388